Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli

M Meincken1, D L Holroyd, M Rautenbach

  • 1UNESCO Associated Centre for Macromolecules, Department of Chemistry, University of Stellenbosch, Matieland, South Africa.

Insights

Antibacterial peptides magainin 2, PGLa, and melittin were studied using atomic force microscopy (AFM) on Escherichia coli. AFM revealed distinct morphological changes in the bacterial cell envelope, indicating varied mechanisms of action for these lytic peptides.

Area of Science:

  • Microbiology
  • Biophysics
  • Biochemistry

Background:

  • Antimicrobial peptides (AMPs) are crucial in innate immunity.
  • Understanding AMPs' mechanisms against bacteria like Escherichia coli is vital.
  • Atomic force microscopy (AFM) offers high-resolution, in situ imaging of cellular processes.

Purpose of the Study:

  • To investigate the morphological effects of magainin 2, PGLa, and melittin on Escherichia coli using AFM.
  • To compare the distinct mechanisms of action of these three lytic peptides at the nanometer scale.

Main Methods:

  • Utilized atomic force microscopy (AFM) for in situ imaging of Escherichia coli.
  • Observed nanometer-scale changes in the bacterial cell envelope before and after treatment with peptides.
  • Analyzed high-resolution images of intact and surviving bacterial cells.

Main Results:

  • All three peptides, magainin 2, PGLa, and melittin, demonstrated lytic activity against Escherichia coli.
  • AFM imaging revealed distinct morphological alterations in the outer and inner membranes of E. coli.
  • Each peptide induced unique changes, suggesting different modes of action.

Conclusions:

  • Magainin 2, PGLa, and melittin exhibit distinct mechanisms for disrupting the Escherichia coli cell envelope.
  • AFM is a powerful tool for visualizing the nanoscale effects of antimicrobial peptides on bacteria.
  • The study provides nanometer-scale insights into peptide-bacterial interactions and potential antimicrobial strategies.